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Abstract Martin-Probst syndrome (MPS) is an X-linked
multisystem neurodevelopmental disorder, reported to be
caused by the p.D59G mutation in RAB40AL. Whereas evi-
dence against the pathogenic role of p.D59G has been pub-
lished, the presence ofRAB40AL p.D59G continues to be used
as a support for MPS diagnosis. Our purpose was to provide
further arguments for excluding pathogenicity of RAB40AL
p.D59G. We detected p.D59G in two healthy males
ascertained as family members of p.D59G carriers who
underwent whole exome sequencing for diagnostic reasons.
Furthermore, we found that p.D59G was present in 2.86 %
(4/140) of randomly selected Polish males with higher
education.
Conclusion: Our findings are inconsistent with a causative
effect of RAB40AL p.D59G on cognitive impairment com-
bined with severe to profound bilateral hearing loss but indi-
cate that p.D59G is a common genetic variation. Our data
emphasize the need for genotyping large sample sizes of
diverse populations as a basic tool in determining variant
pathogenicity.
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Introduction
Martin-Probst syndrome (MPS, MIM %300519) is an X-
linked neurodevelopmental disorder characterized by sensori-
neural hearing loss, intellectual disability and a variety of
dysmorphic features [5]. MPS has been originally described
in three males from a single family. Whereas evidence against
the pathogenic role of p.D59G has been published [2, 6], the
presence of RAB40AL (MIM *300405) p.D59G continues to
be used to support MPS diagnosis as evidenced by a recent
publication by Lee et al. describing the fourth male with MPS
[4]. Since the overlap of symptoms between the case reported
by Lee et al. [4] and originally described patients [5] was only
partial (out of nine features present in all three affected sub-
jects from the first family [5], only four were present in the
patient of Lee et al. [4]), the diagnosis rested mainly on the
detection of the p.D59G mutation in the RAB40AL gene,
which has been proposed to cause MPS [1].
The RAB40AL gene (NG_017150.1) contains one exon of
1713-bp length and more than 70 different single nucleotide
polymorphisms (SNP) in the coding sequence. Many of them
occur at a low frequency and are predicted to be deleterious by
in silico analysis (www.ensembl.org, accessed 10/2014).
However, none of them has been associated with any
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disease. The only mutation identified in RAB40AL is c.176_
177delACinsGA found to segregate with MPS. The variant
represents a dinucleotide change and contains a NM_
001031834.1:c.176A>G transition (rs145606134) co-
occurring with a NM_001031834.1:c.177C>A transversion
(rs138133927). These substitutions, when present together,
are predicted to cause a replacement of aspartic acid by
glycine (GAC>GGA) at codon 59 (p.D59G) [1].
Whereas the report by Lee et al. [4] is potentially important
for refining the spectrum of MPS symptoms, our study pre-
sents new data casting doubt on the pathogenicity of
RAB40AL p.D59G in MPS.
Materials and methods
Patients
Genomic DNA was isolated from peripheral blood from all
available family members (n=6) from two unrelated Polish
families. The index patient in the first family was a 36-year-
old female with profound bilateral sensorineural hearing loss
from infancy and hypothyroid goiter treated with thyroxin
from the age of 15 years. Whole exome sequencing (WES)
in the patient identified two heterozygous mutations in the
SLC26A4 gene (MIM *605646), which allowed the diagnosis
of Pendred syndrome (PDS #274600) (Fig. 1a). The second
index patient was a female with congenital ichthyosis (MIM
#242100) most probably resulting from recessive mutations in
the ALOX12B gene (MIM *603741) (Fig. 1b). Both index
patients were otherwise healthy and their family history was
unremarkable. Males in both families did not present with any
symptoms or signs suggestive of MPS. The brother of the first
index patient graduated from a secondary technical school.
The father of the second index patient used to be a competitive
swimmer and currently working as a lifeguard.
A set of DNA samples (n=140) from males with a com-
pleted higher education was selected from a repository of
DNA samples obtained from randomly chosen permanent
Polish residents and used for studying genetic risk factors
for cardiovascular diseases [3]. All examined individuals gave
a written informed consent for genetic testing and the study
was approved by the local ethics committees.
Methods
Geno t yp i ng o f t h e d i n u c l e o t i d e s ub s t i t u t i o n
(c.176_177delACinsGA) in the RAB40AL leading to
Fig. 1 Detection of RAB40AL p.D59G in the studied individuals. (a,
b) Pedigree of the two Polish families investigated in the study showing
the index patient (arrow) and segregation of p.D59G (*) within the
families; wt indicates the presence of the RAB40AL wild-type allele, na
indicates family members not available for genetic examination. Filled
symbols denote individuals affected with the (a) Pendred syndrome or
(b) congenital ichthyosis, open symbols denote unaffected individuals.
(c)RAB40ALwas PCR amplified in all tested individuals (812-bp product
(*)), specific amplification of the RAB40AL c.176_177delACinsGAvariant
was identified in some of them (751-bp product (**), lane 5). One repre-
sentative gel is shown. M indicates the DNA molecular weight marker
(lane 1). (d) Direct DNA sequencing of the RAB40AL gene confirmed the
presence of c.176A>G transition (rs145606134, shaded blue) and
c.177C>A transversion (rs138133927, shaded yellow) predicting the amino
acid change p.D59G (GAC>GGA). One representative electropherogram
is shown
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p.D59G was performed as described previously using allele-
specific PCR followed by direct Sanger sequencing [6].
Results
The p.D59G in the RAB40AL gene was identified by WES
sequencing in two female probands with distinct medical
problems. Further analysis revealed that in the first family,
p.D59G was inherited by the index patient and her brother
from their healthy mother (Fig. 1a) whereas in the second
family, the variant was transmitted to the index patient from
her healthy father (Fig. 1b). Noteworthy, both males hemizy-
gous for the p.D59G variant in these families do not have
hearing loss, intellectual disability or other phenotypic feature
reported in patients with MPS and they consider themselves
generally healthy.
Studying the prevalence of the p.D59G in a cohort of
Polish males with a completed higher education, we identified
the RAB40AL variant in 4 out of 140 individuals. It corre-
sponds to an allele frequency of 2.86 % in males, which is
typical for a common genetic variation (Fig. 1c, d).
Discussion
Our data provide further strong evidence against the pathoge-
nicity of the RAB40AL p.D59G variant in MPS. Performing
WES, we have detected the RAB40AL p.D59G variant in two
unrelated female patients with a clinical diagnosis other than
MPS. As MPS is an X-linked recessive disorder, we have
studied the segregation of p.D59G in these families and found
that none of the male family members hemizygous for
p.D59G had anymedical problems, and there was no evidence
of MPS in these individuals. Considering that intellectual
disability is one of the main clinical features of MPS, we
aimed to examine the prevalence of the RAB40AL genetic
variant in a cohort of Polish males with a completed higher
education. The resulting data showed a high prevalence
(2.86 %) of p.D59G in this group that is typical of a benign
polymorphism.
Based on recently proposed guidelines for the assessment
of genetic variants potentially involved in X-linked intellec-
tual disability, detection of a variant in more than one male or
individual of the general population argues against its patho-
genic role [7]. In the ESP6500 database (NHLBI GO Exome
Sequencing Project http://evs.gs.washington.edu/EVS/), a
large exome database, the c.176A>G substitution
(rs145606134) was detected in 2 and the c.177C>A substitu-
tion (rs138133927) in 1 out of 6728 alleles of European
Americans (accessed 10/2014).
Furthermore, the prevalence of p.D59G is apparently quite
high in German and Polish populations. Kalscheuer et al.
identified the p.D59G variant in 4 out of 446 index patients
with intellectual disability, although in all cases its causative
role was unlikely [2]. Our group recently found p.D59G by
WES in two males in whom the diagnosis of MPS was
excluded. Furthermore, by screening control DNA samples
(n=810) from a general Polish population, we found p.D59G
in 8/405males and 12/405 females, indicating that it has a high
prevalence (2.47 %) typical of a benign polymorphism [6].
These data suggest that the presence of RAB40AL p.D59G
in the patient described by Lee et al. [4] cannot be regarded as
a proof for the diagnosis ofMPS. Thus, before the true genetic
determinant of MPS is found and appropriately confirmed,
caution should be exerted in accepting that the patient de-
scribed by Lee et al. [4] has MPS as a consequence of
RAB40AL p.D59G.
In the context of previous work [1], our study emphasizes
the importance of investigating large sample sizes of diverse
populations as a basic tool in determining variant pathogenic-
ity. Considering the high prevalence of RAB40AL p.D59G in
the general population and an increasing use of whole exome
sequencing in the clinic, our results should help to avoid
diagnostic pitfalls.
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